Is birthweight associated with total and aggressive/lethal prostate cancer risks A systematic review and meta-analysis

British Journal of Cancer

Volumn 114, Issue 7, 2016, Pages 839-848

  Zhou, Cindy Ke ^a   Sutcliffe, Siobhan ^b   Welsh, Judith ^c   Mackinnon, Karen ^d   Kuh, Diana ^d   Hardy, Rebecca ^d   Cook, Michael B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Washington University in St Louis School of Medicine   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

birthweight; meta analysis; prostatic neoplasms; review

Indexed keywords

BIRTH WEIGHT; CANCER GROWTH; CANCER RISK; DISEASE ASSOCIATION; EDUCATIONAL STATUS; EMPLOYMENT STATUS; HUMAN; MALE; MEDICAL RECORD; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; CASE CONTROL STUDY; PATHOLOGY; PROGNOSIS; PROSTATIC NEOPLASMS;

BIRTH WEIGHT; CASE-CONTROL STUDIES; HUMANS; MALE; PROGNOSIS; PROSTATIC NEOPLASMS; RISK ASSESSMENT;

EID: 84959553832     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2016.38     Document Type: Review

References (51)

1. Adegboye ARA, Heitmann BL (2008) Accuracy and correlates of maternal recall of birthweight and gestational age. BJOG 115(7): 886-893.
2. Ahlgren M, Wohlfahrt J, Olsen LW, Sorensen TI, Melbye M (2007) Birth weight and risk of cancer. Cancer 110(2): 412-419.
3. Al Olama AA, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, Benlloch S, Hazelett DJ, Wang Z, Saunders E, Leongamornlert D, Lindstrom S, Jugurnauth-Little S, Dadaev T, Tymrakiewicz M, Stram DO, Rand K, Wan P, Stram A, Sheng X, Pooler LC, Park K, Xia L, Tyrer J, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Yeager M, Burdette L, Chung CC, Hutchinson A, Yu K, Goh C, Ahmed M, Govindasami K, Guy M, Tammela TLJ, Auvinen A, Wahlfors T, Schleutker J, Visakorpi T, Leinonen KA, Xu J, Aly M, Donovan J, Travis RC, Key TJ, Siddiq A, Canzian F, Khaw K-T, Takahashi A, Kubo M, Pharoah P, Pashayan N, Weischer M, Nordestgaard BG, Nielsen SF, Klarskov P, Røder MA, Iversen P, Thibodeau SN, McDonnell SK, Schaid DJ, Stanford JL, Kolb S, Holt S, Knudsen B, Coll AH, Gapstur SM, Diver WR, Stevens VL, Maier C, Luedeke M, Herkommer K, Rinckleb AE, Strom SS, Pettaway C, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chokkalingam AP, Cannon-Albright L, Cybulski C, Woko"orczyk D, Kluz?niak W, Park J, Sellers T, Lin H-Y, Isaacs WB, Partin AW, Brenner H, Dieffenbach AK, Stegmaier C, Chen C, Giovannucci EL, Ma J, Stampfer M, Penney KL, Mucci L, John EM, Ingles SA, Kittles RA, Murphy AB, Pandha H, Michael A, Kierzek AM, Blot W, Signorello LB, Zheng W, Albanes D, Virtamo J, Weinstein S, Nemesure B, Carpten J, Leske C, Wu S-Y, Hennis A, Kibel AS, Rybicki BA, Neslund-Dudas C, Hsing AW, Chu L, Goodman PJ, Klein EA, Zheng SL, Batra J, Clements J, Spurdle A, Teixeira MR, Paulo P, Maia S, Slavov C, Kaneva R, Mitev V, Witte JS, Casey G, Gillanders EM, Seminara D, Riboli E, Hamdy FC, Coetzee GA, Li Q, Freedman ML, Hunter DJ, Muir K, Gronberg H, Neal DE, Southey M, Giles GG, Severi G. The B, Prostate Cancer Cohort C, The PC, The CC, The G-ONECCook MB, Nakagawa H, Wiklund F, Kraft P, Chanock SJ, Henderson BE, Easton DF, Eeles RA, Haiman CA (2014) A meta-Analysis of 87, 040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat Genet 46(10): 1103-1109.
4. Baik I, DeVito WJ, Ballen K, Becker PS, Okulicz W, Liu Q, Delpapa E, Lagiou P, Sturgeon S, Trichopoulos D, Quesenberry PJ, Hsieh CC (2005) Association of fetal hormone levels with stem cell potential: evidence for early life roots of human cancer. Cancer Res 65(1): 358-363.
5. Barker DJ, Osmond C, Thornburg KL, Kajantie E, Eriksson JG (2012) A possible link between the pubertal growth of girls and prostate cancer in their sons. Am J Hum Biol 24(4): 406-410.
6. Boland LL, Mink PJ, Bushhouse SA, Folsom AR (2003) Weight and length at birth and risk of early-onset prostate cancer (United States) Cancer Causes Control 14(4): 335-338.
7. Capittini C, Bergamaschi P, De Silvestri A, Marchesi A, Genovese V, Romano B, Tinelli C, Salvaneschi L (2011) Birth-weight as a risk factor for cancer in adulthood: the stem cell perspective. Maturitas 69(1): 91-93.
8. Chene G, Thompson SG (1996) Methods for summarizing the risk associations of quantitative variables in epidemiologic studies in a consistent form. Am J Epidemiol 144(6): 610-621.
9. Cook MB, Gamborg M, Aarestrup J, Sorensen TI, Baker JL (2013) Childhood height and birth weight in relation to future prostate cancer risk: a cohort study based on the copenhagen school health records register. Cancer Epidemiol Biomarkers Prev 22(12): 2232-2240.
10. Cunha GR, Donjacour AA, Cooke PS, Mee H, Bigsby RM, Higgins SJ, Sugimura Y (1987) The endocrinology and developmental biology of the prostate. Endocr Rev 8(3): 338-362.
11. Davidson S, Hod M, Merlob P, Shtaif B (2006) Leptin, insulin, insulin-like growth factors and their binding proteins in cord serum: insight into fetal growth and discordancy. Clin Endocrinol 65(5): 586-592.
12. dos Santos Silva I, Stavola BD, McCormack V. Collaborative Group on Pre-Natal Risk F, Subsequent Risk of Breast C (2008) Birth size and breast cancer risk: re-Analysis of individual participant data from 32 studies. PLoS Med 5(9): e193.
13. Eichholzer M, Platz EA, Bienstock JL, Monsegue D, Akereyeni F, Hollis BW, Horst R, Rifai N, Pollak MN, Barbir A, Agurs-Collins T, Rohrmann S (2013) Racial variation in vitamin D cord blood concentration in white and black male neonates. Cancer Causes Control 24(1): 91-98.
14. Eide MG, Oyen N, Skjaerven R, Nilsen ST, Bjerkedal T, Tell GS (2005) Size at birth and gestational age as predictors of adult height and weight. Epidemiology 16(2): 175-181.
15. Ekbom A (1998) Growing evidence that several human cancers may originate in utero. Semin Cancer Biol 8(4): 237-244.
16. Ekbom A, Hsieh CC, Lipworth L, Wolk A, Ponten J, Adami HO, Trichopoulos D (1996) Perinatal characteristics in relation to incidence of and mortality from prostate cancer. BMJ 313(7053): 337-341.
17. Ekbom A, Wuu J, Adami HO, Lu CM, Lagiou P, Trichopoulos D, Hsieh C (2000) Duration of gestation and prostate cancer risk in offspring. Cancer Epidemiol Biomarkers Prev 9(2): 221-223.
18. Ellem SJ, Risbridger GP (2009) The dual, opposing roles of estrogen in the prostate. Ann NY Acad Sci 1155: 174-186.
19. Eriksson M, Wedel H, Wallander MA, Krakau I, Hugosson J, Carlsson S, Svardsudd K (2007) The impact of birth weight on prostate cancer incidence and mortality in a population-based study of men born in 1913 and followed up from 50 to 85 years of age. Prostate 67(11): 1247-1254.
20. Gerdtsson A, Poon JB, Thorek DL, Mucci LA, Evans MJ, Scardino P, Abrahamsson PA, Nilsson P, Manjer J, Bjartell A, Malm J, Vickers A, Freedland SJ, Lilja H, Ulmert D (2015) Anthropometric measures at multiple times throughout life and prostate cancer diagnosis, metastasis, and death. Eur Urol 17(15): 00226-2.
21. Henderson BE, Bernstein L, Ross RK, Depue RH, Judd HL (1988) The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. Br J Cancer 57(2): 216-218.
22. Jaworowicz DJJ, Nie J, Bonner MR, Han D, Vito D, Hutson A, Potischman N, Trevisan M, Muti P, Freudenheim JL (2010) Agreement between self-reported birth weight and birth certificate weights. J Devl Orig Health Dis 1(02): 106-113.
23. Kajantie E, Osmond C, Barker DJ, Forsen T, Phillips DI, Eriksson JG (2005) Size at birth as a predictor of mortality in adulthood: a follow-up of 350 000 person-years. Int J Epidemiol 34(3): 655-663.
24. Kuh D, Ben-Shlomo Y (2004) A Life Course Approach to Chronic Disease Epidemiology: Tracing the Origins of Ill-Health from Early to Adult Life. 2nd edn, Fully revised. Oxford University Press: Oxford, UK
25. Lahmann PH, Lissner L, Wallstrom P, Gullberg B, Olsson H (2010) Birth weight and current body size in relation to risk of prostate cancer: the Malmo Diet and Cancer Study, Sweden. Obes Rev 11: 354-355.
26. Lahmann PH, Wallstrom P, Lissner L, Olsson H, Gullberg B (2012) Measures of birth size in relation to risk of prostate cancer: the Malmo Diet and Cancer Study, Sweden. J Dev Orig Health Dis 3(6): 442-449.
27. Lai GY, Rohrmann S, Agurs-Collins T, Sutcliffe CG, Bradwin G, Rifai N, Bienstock JL, Platz EA (2011) Racial variation in umbilical cord blood leptin concentration in male babies. Cancer Epidemiol Biomarkers Prev 20(4): 665-671.
28. Lawson JS (1998) Prostate cancer, birthweight, and diet. Epidemiology 9(2): 217.
29. Lope V, Garcia-Esquinas E, Aragones N, Kogevinas M, Dierssen-Sotos T, Altzibar J, Ardanaz E, Martin V, Tardon A, Alguacil J, Crous-Bou M, Salas D, Jimenez-Moleon JJ, Pollan M (2012) Birth and childhood characteristics and risk of adult hormone dependent cancers: MCC-Spain. Epidemiology 23(5): S510.
30. McCormack VA, dos Santos Silva I, Koupil I, Leon DA, Lithell HO (2005) Birth characteristics and adult cancer incidence: Swedish cohort of over 11, 000 men and women. Int J Cancer 115(4): 611-617.
31. Nilsen TI, Romundstad PR, Troisi R, Vatten LJ (2005) Birth size and subsequent risk for prostate cancer: a prospective population-based study in Norway. Int J Cancer 113(6): 1002-1004.
32. Orbak Z, Darcan S, Coker M, Goksen D (2001) Maternal and fetal serum insulin-like growth factor-I (IGF-I) IGF binding protein-3 (IGFBP-3), leptin levels and early postnatal growth in infants born asymmetrically small for gestational age. J Pediatr Endocrinol Metab 14(8): 1119-1127.
33. Parent ME, Siemiatycki J, Goldberg M, Desy M (2008) Birthweight, obesity during childhood, adolescence and adulthood, and prostate cancer -preliminary data from the PROTEuS study. Am J Epidemiol 167(11): S62-S62.
34. Peck JD, Hulka BS, Savitz DA, Baird D, Poole C, Richardson BE (2003) Accuracy of fetal growth indicators as surrogate measures of steroid hormone levels during pregnancy. Am J Epidemiol 157(3): 258-266.
35. Petridou E, Panagiotopoulou K, Katsouyanni K, Spanos E, Trichopoulos D (1990) Tobacco smoking, pregnancy estrogens, and birth weight. Epidemiology 1(3): 247-250.
36. Platz EA, Giovannucci E, Rimm EB, Curhan GC, Spiegelman D, Colditz GA, Willett WC (1998) Retrospective analysis of birth weight and prostate cancer in the Health Professionals Follow-up Study. Am J Epidemiol 147(12): 1140-1144.
37. Potischman N, Troisi R, Thadhani R, Hoover RN, Dodd K, Davis WW, Sluss PM, Hsieh CC, Ballard-Barbash R (2005) Pregnancy hormone concentrations across ethnic groups: implications for later cancer risk. Cancer Epidemiol Biomarkers Prev 14(6): 1514-1520.
38. Prins GS, Ho SM (2010) Early-life estrogens and prostate cancer in an animal model. J Dev Orig Health Dis 1(6): 365-370.
39. Richard A, Rohrmann S, Zhang L, Eichholzer M, Basaria S, Selvin E, Dobs AS, Kanarek N, Menke A, Nelson WG, Platz EA (2014) Racial variation in sex steroid hormone concentration in black and white men: a meta-Analysis. Andrology 2(3): 428-435.
40. Rohrmann S, Sutcliffe CG, Bienstock JL, Monsegue D, Akereyeni F, Bradwin G, Rifai N, Pollak MN, Agurs-Collins T, Platz EA (2009) Racial variation in sex steroid hormones and the insulin-like growth factor axis in umbilical cord blood of male neonates. Cancer Epidemiol Biomarkers Prev 18(5): 1484-1491.
41. Ross RK, Henderson BE (1994) Do diet and androgens alter prostate cancer risk via a common etiologic pathway?. J Natl Cancer Inst 86(4): 252-255.
42. Rowlands M-A, Gunnell D, Harris R, Vatten LJ, Holly JMP, Martin RM (2009) Circulating insulin-like growth factor (IGF) peptides and prostate cancer risk: a systematic review and meta-Analysis. Int J Cancer 124(10): 2416-2429.
43. Ruan W, Powell-Braxton L, Kopchick JJ, Kleinberg DL (1999) Evidence that insulin-like growth factor I and growth hormone are required for prostate gland development. Endocrinology 140(5): 1984-1989.
44. Shibata A, Minn AY (2000) Perinatal sex hormones and risk of breast and prostate cancers in adulthood. Epidemiol Rev 22(2): 239-248.
45. Skalkidou A, Petridou E, Papathom E, Salvanos H, Chrousos G, Trichopoulos D (2002) Birth size and neonatal levels of major components of the IGF system: implications for later risk of cancer. J Pediatr Endocrinol Metab 15(9): 1479-1486.
46. Strohsnitter WC, Savarese TM, Low HP, Chelmow DP, Lagiou P, Lambe M, Edmiston K, Liu Q, Baik I, Noller KL, Adami HO, Trichopoulos D, Hsieh CC (2008) Correlation of umbilical cord blood haematopoietic stem and progenitor cell levels with birth weight: implications for a prenatal influence on cancer risk. Br J Cancer 98(3): 660-663.
47. Sutcliffe S, Colditz GA (2013) Prostate cancer: is it time to expand the research focus to early-life exposures?. Nat Rev Cancer 13(3): 208-518.
48. Sutcliffe S, Giovannucci E, Willett WC, Platz EA (2007) A prospective study of birth weight and risk of prostate cancer. Proc Am Assoc Cancer Res Annu Meet 48: 820-820.
49. Tibblin G, Eriksson M, Cnattingius S, Ekbom A (1995) High birthweight as a predictor of prostate cancer risk. Epidemiology 6(4): 423-424.
50. Wadsworth M, Kuh D, Richards M, Hardy R (2006) Cohort Profile: The 1946 National Birth Cohort (MRC National Survey of Health and Development) Int J Epidemiol 35(1): 49-54.
51. World Cancer Research Fund International (2014) Continuous Update Project Report: Diet, Nutrition, Physical Activity, and Prostate Cancer. Available at: www.wcrf.org/sites/default/files/Prostate-Cancer-2014-Report.pdf (accessed on 8 July 2015